Evidence map›Paper›PMID 31075228›Full record

ArticleBiochimica et biophysica acta. Biomembranes2019

Activity and characterization of a pH-sensitive antimicrobial peptide.

Morgan A Hitchner, Luis E Santiago-Ortiz, Matthew R Necelis, David J Shirley, Thaddeus J Palmer, Katharine E Tarnawsky, Timothy D Vaden, Gregory A Caputo

Open access · greenAbstract read
In one paragraph

Article in Biochimica et biophysica acta. Biomembranes, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed
3.7field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed, 48 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Review
  14. Review
  15. Review
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 1 institution in 1 country.

Morgan A HitchnerDepartment of Chemistry and Biochemistry, Rowan University, 201 Mullica Hill Road, Glassboro, NJ 08028, United States of America.
Luis E Santiago-OrtizDepartment of Chemistry and Biochemistry, Rowan University, 201 Mullica Hill Road, Glassboro, NJ 08028, United States of America.
Matthew R NecelisDepartment of Chemistry and Biochemistry, Rowan University, 201 Mullica Hill Road, Glassboro, NJ 08028, United States of America.
David J ShirleyDepartment of Chemistry and Biochemistry, Rowan University, 201 Mullica Hill Road, Glassboro, NJ 08028, United States of America.
Thaddeus J PalmerDepartment of Chemistry and Biochemistry, Rowan University, 201 Mullica Hill Road, Glassboro, NJ 08028, United States of America.
Katharine E TarnawskyDepartment of Chemistry and Biochemistry, Rowan University, 201 Mullica Hill Road, Glassboro, NJ 08028, United States of America.
Timothy D VadenDepartment of Chemistry and Biochemistry, Rowan University, 201 Mullica Hill Road, Glassboro, NJ 08028, United States of America.
Gregory A CaputoDepartment of Chemistry and Biochemistry, Rowan University, 201 Mullica Hill Road, Glassboro, NJ 08028, United States of America; Department of Molecular and Cellular Biosciences, Rowan University, 201 Mullica Hill Road, Glassboro, NJ 08028, United States of America. Electronic address: caputo@rowan.edu.
Rowan University · US

Funding

Bridges to Baccalaureate: Cumberland County College Bridge to RowanR25GM119973 · NIGMS · ROWAN UNIVERSITY · PI KRUFKA, ALISON, RANDA, MARK · 2017 to 2021
$1.3M
Structure-Activity Relationship in Host Defense PeptidesR15GM094330 · NIGMS · ROWAN UNIVERSITY · PI CAPUTO, GREGORY ALEXANDER · 2010 to 2010
$292k
NIGMS NIH HHS R15 GM094330NIGMS NIH HHS R25 GM119973
6 · The paper itself

Abstract

Antimicrobial peptides (AMPs) have been an area of great interest, due to the high selectivity of these molecules toward bacterial targets over host cells and the limited development of bacterial resistance to these molecules throughout evolution. Previous work showed that when Histidine was incorporated into the peptide C18G it lost antimicrobial activity. The role of pH on activity and biophysical properties of the peptide was investigated to explain this phenomenon. Minimal inhibitory concentration (MIC) results demonstrated that decreased media pH increased antimicrobial activity. Trichloroethanol (TCE) quenching and red-edge excitation spectroscopy (REES) showed a clear pH dependence on peptide aggregation in solution. Trp fluorescence was used to monitor binding to lipid vesicles and demonstrated the peptide binds to anionic bilayers at all pH values tested, however, binding to zwitterionic bilayers was enhanced at pH 7 and 8 (above the His pKa). Dual Quencher Analysis (DQA) confirmed the peptide inserted more deeply in PC:PG and PE:PG membranes, but could insert into PC bilayers at pH conditions above the His pKa. Bacterial membrane permeabilization assays which showed enhanced membrane permeabilization at pH 5 and 6 but vesicle leakage assays indicate enhanced permeabilization of PC and PC:PG bilayers at neutral pH. The results indicate the ionization of the His side chain affects the aggregation state of the peptide in solution and the conformation the peptide adopts when bound to bilayers, but there are likely more subtle influences of lipid composition and properties that impact the ability of the peptide to form pores in membranes.

Indexed as

Amino Acid SequenceAnti-Bacterial AgentsAnti-Infective AgentsAntimicrobial Cationic PeptidesCell MembraneCell Membrane PermeabilityHistidineHydrogen-Ion ConcentrationLipid BilayersPeptidesPhosphatidylcholinesPhosphatidylglycerolsStructure-Activity RelationshipAnti-Bacterial AgentsAnti-Infective AgentsAntimicrobial Cationic PeptidesC18G peptideHistidineLipid BilayersPeptidesPhosphatidylcholinesPhosphatidylglycerolsAntimicrobial peptidesFluorescenceLipid bindingMembrane permeabilizationpH-dependence

Identifiers

PMID31075228
PMCPMC6721999
OpenAlexW2943929035

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.